AliveCor QT Service vs Zio XT ECG Monitoring System
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if your primary need is instant and accurate QT/QTc interval measurement to assess cardiac safety, particularly when making medication prescribing decisions. This tool is ideal for healthcare professionals utilizing AliveCor 6-Lead ECG devices who require rapid, AI-powered analysis for immediate clinical insights.
View AliveCor QT Service →Choose Zio XT ECG Monitoring System if…
Choose Zio XT ECG Monitoring System if you require continuous, long-term ambulatory cardiac monitoring for up to 14 days to detect and diagnose arrhythmias. This wearable, lead-free biosensor is well-suited for patients needing extended monitoring with high comfort and compliance, providing comprehensive data for expert review and AI-driven analysis.
View Zio XT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Zio XT ECG Monitoring System |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact for pricing |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Cloud-based (AWS EC2 platform), no on-premise hardware required. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemThe Zio XT system offers superior patient usability for continuous monitoring due to its wearable, lead-less, and water-resistant biosensor design, allowing patients to maintain normal daily activities. In contrast, AliveCor QT Service relies on a separate 6-Lead device for ECG acquisition, which may be less seamless for extended wear.
Clinical Value
TieBoth tools offer significant clinical value but address different primary needs. AliveCor QT Service provides instant, accurate QT/QTc interval measurements crucial for cardiac safety and medication management. Zio XT offers comprehensive continuous cardiac monitoring for up to 14 days, enabling accurate arrhythmia detection and diagnosis over an extended period.
Pricing & Value
Zio XT ECG Monitoring SystemZio XT provides greater pricing transparency by offering specific cost examples for the UK and proposed Medicare rates in the US. AliveCor QT Service requires contacting the vendor for pricing details, making it more challenging for potential users to assess immediate value and compare costs upfront.
Enterprise Readiness
AliveCor QT ServiceWhile both tools are FDA-cleared, HIPAA compliant, and offer BAAs, AliveCor QT Service explicitly highlights an API available for integration with a broader range of enterprise platforms, including EHR, SDK, CRM, EDC, and PSP platforms. This indicates a more comprehensive approach to interoperability and enterprise integration compared to Zio XT's general cloud-based deployment.
Innovation
Zio XT ECG Monitoring SystemZio XT demonstrates greater innovation through its integrated wearable biosensor for extended, lead-less continuous cardiac monitoring, significantly enhancing patient comfort and data collection methodology. While AliveCor's instant AI-driven QT measurement is valuable, Zio XT's approach to long-term, patient-friendly monitoring represents a more disruptive innovation in the overall patient care pathway.
Support & Docs
Zio XT ECG Monitoring SystemZio XT offers more robust and accessible support, including 24/7 customer care availability via phone and a dedicated MyZio app for patient resources, symptom logging, and instructional videos. AliveCor provides comprehensive documentation and contact options, but does not specify 24/7 support availability for its service.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Zio XT ECG Monitoring System |
|---|---|---|
| Tool Name | AliveCor QT Service | Zio XT ECG Monitoring System |
| Company | AliveCor | iRhythm Technologies |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | The Zio XT ECG Monitoring System by iRhythm Technologies offers a wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis. |
| Key Functionality | Measures QT and QTc intervals (Bazett's and Fridericia's formulas) from AliveCor 6-Lead ECGs. | Continuous ambulatory cardiac monitoring for up to 14 days using a wearable single-lead ECG biosensor. |
| ECG Lead Type | 6-Lead ECGs | Single-lead ECG biosensor |
| Monitoring Duration | Instant QT measurements | Up to 14 days of continuous monitoring |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Zio XT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or Zio XT ECG Monitoring System
Backers
Who funded each tool's parent company.